M/13/021 – Aspen / MSD NL 8 B.V.

Transaction details

The acquisition of MSD NL 8 B.V. (a subsidiary of Merck & Co Incorporated) by Aspen Pharmacare Holdings Limited has been cleared by the Competition Authority.

Notification date Decision date
Thursday July 18, 2013 Wednesday, August 14, 2013
Parties Involved Business activities
Aspen Pharmacare Holdings Limited

Aspen is a globally competitive producer of high quality affordable generic medicines and is involved in the development, registration, manufacture, import, marketing, selling and distribution of pharmaceutical products.


MSD BV is comprised of the API manufacturing business which manufactures unprocessed APIs both for Merck and Co Incorporated and the market generally.

Economic sector Media merger
The pharmaceutical industry No
Submissions from third parties due by:
Phase 1 Phase 2
Monday, July 29, 2013
Current status: Completed
Cleared (Phase 1)
Authorised Officer Assigned Contact Details
Andrew Rae

Tel: 01-804 5420

Media enquiries: MKC Communications: 01 7038600

Return to Merger Notifications

Haven’t found what you’re looking for?